The effect of generic market entry on antibiotic prescriptions in the United States

Cecilia Kållberg; Jemma Hudson; Hege Salvesen Blix; Christine Årdal; Eili Klein; Morten Lindbæk; Kevin Outterson; John-Arne Røttingen; Ramanan Laxminarayan

doi:10.1038/s41467-021-23049-4

Nature Communications (May 2021)

The effect of generic market entry on antibiotic prescriptions in the United States

Cecilia Kållberg,
Jemma Hudson,
Hege Salvesen Blix,
Christine Årdal,
Eili Klein,
Morten Lindbæk,
Kevin Outterson,
John-Arne Røttingen,
Ramanan Laxminarayan

Affiliations

Cecilia Kållberg: Faculty of Medicine, Institute of Health and Society, University of Oslo
Jemma Hudson: Health Services Research Unit, University of Aberdeen
Hege Salvesen Blix: Norwegian Institute of Public Health
Christine Årdal: Norwegian Institute of Public Health
Eili Klein: Center for Disease Dynamics, Economics and Policy
Morten Lindbæk: Faculty of Medicine, Institute of Health and Society, University of Oslo
Kevin Outterson: School of Law, Boston University
John-Arne Røttingen: Faculty of Medicine, Institute of Health and Society, University of Oslo
Ramanan Laxminarayan: Center for Disease Dynamics, Economics and Policy

DOI: https://doi.org/10.1038/s41467-021-23049-4
Journal volume & issue: Vol. 12, no. 1
pp. 1 – 9

Abstract

Read online

Generics contribute to increased availability of antibiotics, benefiting healthcare systems but potentially leading to increased consumption with implications for antibiotic stewardship and resistance. Here, the authors found no consistent changes in prescribing patterns of the 13 antibiotics that entered the US market as generics from 2000–2012.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal